The first and only oral GLP-1 for weight loss in adults is now available to consumers. Drugmaker Novo Nordisk announced Monday that its daily oral Wegovy pill is now available by prescription.

Novo Nordisk has won the race to secure approval from the U.S. Food and Drug Administration for the first weight-loss drug to be administered orally. Jules Rimmer is a markets reporter in ...

Weight Lifting Simulator buffs up Roblox characters. Trump’s golf course takeover sparks outrage 'Massive betrayal': Ghislaine Maxwell’s prison treatment sparks outcry Child stars who went on to have ...

Artur is a copywriter and SEO specialist, as well as a small business owner. In his free time, he loves to play computer games and is glad that he was able to connect his professional career with his ...

Martha Stewart is the most active 84-year-old I’ve ever met. Juggling her many business ventures, constant travel and hectic commuting schedule, she still makes time to exercise “religiously” at 6:30 ...

One of Eli Lilly’s most promising new obesity drugs helped patients lose about 28.7% of their body weight while also reducing pain associated with knee osteoarthritis. The drug giant’s LLY stock was ...

A new weight-loss drug that Eli Lilly is testing is helping patients in a late-stage trial lose an average of 28.7% of their body weight and offered "substantial" relief from osteoarthritis pain. In ...

Eli Lilly LLY-0.58%decrease; red down pointing triangle said its next generation weight-loss drug retatrutide helped people lose up to 28.7% of their body weight after more than a year of treatment, ...

Please provide your email address to receive an email when new articles are posted on . Adults with obesity and knee osteoarthritis had reductions in body weight and knee pain with retatrutide. More ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Eli Lilly’s ...